| Breakdown | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.68M | 4.97M | 13.54M | 26.95M | 21.47M |
| Gross Profit | -10.77M | -10.09M | -6.83M | 16.20M | 13.23M |
| EBITDA | -10.30M | -10.85M | -13.25M | 5.85M | 4.95M |
| Net Income | -23.09M | -20.27M | -21.15M | -4.34M | -4.87M |
Balance Sheet | |||||
| Total Assets | 18.43M | 25.89M | 35.51M | 52.40M | 52.98M |
| Cash, Cash Equivalents and Short-Term Investments | 83.86K | 211.49K | 363.31K | 333.23K | 587.93K |
| Total Debt | 49.88M | 16.27M | 16.07M | 19.87M | 27.80M |
| Total Liabilities | 57.86M | 47.35M | 41.01M | 43.72M | 47.97M |
| Stockholders Equity | -39.43M | -21.46M | -5.50M | 8.68M | 5.01M |
Cash Flow | |||||
| Free Cash Flow | -3.75M | -3.30M | 323.72K | 1.58M | -2.63M |
| Operating Cash Flow | -3.42M | -2.74M | 4.10M | 13.28M | 2.26M |
| Investing Cash Flow | 163.84K | 1.33M | -3.65M | -11.69M | -4.89M |
| Financing Cash Flow | 3.13M | 1.26M | -416.51K | -1.84M | 2.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$1.29T | 7.65 | 16.65% | 6.76% | -9.81% | -8.84% | |
67 Neutral | HK$416.02M | 2.38 | 29.99% | ― | -5.34% | 400.80% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
50 Neutral | HK$1.68B | -0.39 | -35.49% | ― | 39.42% | 56.89% | |
43 Neutral | HK$106.92M | -6.03 | -26.94% | ― | -0.55% | -340.00% | |
41 Neutral | HK$121.69M | -0.17 | 15.69% | ― | -18.76% | -76.89% | |
40 Underperform | HK$234.71M | -1.19 | 37.85% | ― | -9.85% | 20.71% |